BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 19959938)

  • 1. Induction of invasive growth in a gallbladder cancer cell line by hepatocyte growth factor in vitro.
    Shimura H; Date K; Matsumoto K; Nakamura T; Tanaka M
    Jpn J Cancer Res; 1995 Jul; 86(7):662-9. PubMed ID: 7559084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of HGF-PARP-1 signaling in invasion of ovarian cancer cells.
    Wei W; Lv S; Zhang C; Tian Y
    Int J Clin Exp Pathol; 2018; 11(7):3310-3317. PubMed ID: 31949706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.
    Wang Y; Ma J; Shen H; Wang C; Sun Y; Howell SB; Lin X
    Oncol Rep; 2014 Nov; 32(5):2150-8. PubMed ID: 25174950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.
    Shimbo A; Kajiyama H; Tamauchi S; Yoshikawa N; Ikeda Y; Nishino K; Suzuki S; Niimi K; Sakata J; Kikkawa F
    Oncol Rep; 2019 Dec; 42(6):2323-2332. PubMed ID: 31578579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.
    Pakuła M; Witucka A; Uruski P; Radziemski A; Moszyński R; Szpurek D; Maksin K; Woźniak A; Sajdak S; Tykarski A; Mikuła-Pietrasik J; Książek K
    Sci Rep; 2019 May; 9(1):7587. PubMed ID: 31110245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.
    Kuang W; Deng Q; Deng C; Li W; Shu S; Zhou M
    Am J Transl Res; 2017; 9(8):3816-3826. PubMed ID: 28861172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.
    Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations.
    Chen YC; Allen SG; Ingram PN; Buckanovich R; Merajver SD; Yoon E
    Sci Rep; 2015 May; 5():9980. PubMed ID: 25984707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.
    Masli S; Sheibani N; Cursiefen C; Zieske J
    Curr Eye Res; 2014 Aug; 39(8):759-74. PubMed ID: 24559320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.
    Yang X; Li P; Yang X; Qin C; Cao Q; Zhang Z; Wang M; Cai H; Gu J; Tao J; Gu M; Lu Q; Yin C
    Int J Genomics; 2013; 2013():473242. PubMed ID: 24367787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.
    Miyata Y; Sakai H
    Int J Mol Sci; 2013 Jun; 14(6):12249-72. PubMed ID: 23749112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.
    Miyata Y; Watanabe S; Kanetake H; Sakai H
    BMC Cancer; 2012 Aug; 12():372. PubMed ID: 22928942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin-1 and VEGF in inflammatory bowel disease.
    Alkim C; Sakiz D; Alkim H; Livaoglu A; Kendir T; Demirsoy H; Erdem L; Akbayir N; Sokmen M
    Libyan J Med; 2012; 7():. PubMed ID: 22299021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway.
    Lu Z; Ding L; Hong H; Hoggard J; Lu Q; Chen YH
    Exp Cell Res; 2011 Aug; 317(13):1935-46. PubMed ID: 21641901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor enhances ovarian cancer cell invasion through downregulation of thrombospondin-1.
    Wei W; Kong B; Yang Q; Qu X
    Cancer Biol Ther; 2010 Jan; 9(2):79-87. PubMed ID: 19959938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion.
    Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B
    J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
    Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
    Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
    Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
    J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.